CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Ajanta Pharma Ltd.

NSE : AJANTPHARMEQ BSE : 532331 ISIN CODE : INE031B01049Industry : Pharmaceuticals

News

  • Ajanta Pharma - Analysts/Institutional Investor Meet/Con. Call Updates 09 Mar 2026 | 08:49 | Dion Global

    Ajanta Pharma Limited has informed the Exchange about Participation in Investor Conferencemore...

  • Ajanta Pharma - Participation In Investor Conference 09 Mar 2026 | 08:44 | Dion Global

    Pls find enclosed intimation w.r.t Participation in Investor Conference.more...

  • Ajanta Pharma - Rumour Verification - Regulation 30(11) 10 Feb 2026 | 10:23 | Dion Global

    Ajanta Pharma Limited has informed the Exchange about Rumour Verification - Regulation 30(11)more...

  • Ajanta Pharma - Rumour verification - Regulation 30(11) 10 Feb 2026 | 10:18 | Dion Global

    Pls find enclosed Clarification on Market Rumour.more...

  • Ajanta Pharma - Analysts/Institutional Investor Meet/Con. Call Updates 05 Feb 2026 | 11:10 | Dion Global

    Ajanta Pharma Limited has informed the Exchange about Transcriptmore...

  • Ajanta Pharma - Announcement under Regulation 30 (LODR)-Earnings Call Transcript 05 Feb 2026 | 11:06 | Dion Global

    Pls find enclosed Earnings Call Transcriptmore...

  • Ajanta Pharma - Analysts/Institutional Investor Meet/Con. Call Updates 02 Feb 2026 | 10:55 | Dion Global

    Ajanta Pharma Limited has informed the Exchange about Participation in Investor Conferencemore...

  • Ajanta Pharma - Participation In Investor Conference 02 Feb 2026 | 10:52 | Dion Global

    Pls find enclosed intimation w.r.t Participation in Investor Conferencemore...

  • Ajanta Pharma - Copy of Newspaper Publication 02 Feb 2026 | 10:36 | Dion Global

    Ajanta Pharma Limited has informed the Exchange about Copy of Newspaper Publicationmore...

  • Ajanta Pharma - Analysts/Institutional Investor Meet/Con. Call Updates 30 Jan 2026 | 17:47 | Dion Global

    Ajanta Pharma Limited has informed the Exchange about Link of Recordingmore...

  • Ajanta Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 30 Jan 2026 | 17:44 | Dion Global

    Pls find enclosed Audio recording of Earnings call conducted on 30th January 2026more...

  • Ajanta Pharma Q3 net profit down 2.94% at Rs 245.04 cr 30 Jan 2026 | 15:30 | Dion Global

    The company reported standalone net profit of Rs 245.04 crore for the quarter ended December 31 2025 as compared to Rs 252.45 crore in the s...more...

  • Ajanta Pharma - General Updates 30 Jan 2026 | 15:23 | Dion Global

    Ajanta Pharma Limited has informed the Exchange about General Updates- Vesting and Cash Settlement of Stock Appreciation Rights (SARs) and Cancellati...more...

  • Ajanta Pharma - Intimation Of Vesting And Cash Settlement Of Stock Appreciation Rights (Sars) And Cancellation Of Employee St 30 Jan 2026 | 15:19 | Dion Global

    Pls find enclosed Intimation of vesting of SARs and cancellation of ESOPsmore...

  • Ajanta Pharma - Outcome of Board Meeting 30 Jan 2026 | 15:10 | Dion Global

    Ajanta Pharma Limited has informed the Exchange regarding Board meeting held on January 30 2026.more...

  • Ajanta Pharma - Board Meeting Outcome for Board Meeting Outcome 30 Jan 2026 | 15:07 | Dion Global

    Pls find enclosed Board Meeting Outcomemore...

  • Ajanta Pharma - Unaudited Financial Results For Quarter Ended 31St December 2025. 30 Jan 2026 | 15:04 | Dion Global

    Pls find enclosed results for quarter ended 31st December 2025.more...

  • Ajanta Pharma - Outcome of Board Meeting 30 Jan 2026 | 15:04 | Dion Global

    Ajanta Pharma Limited has submitted to the Exchange the financial results for the period ended December 31 2025.more...

  • Ajanta Pharma - Rumour Verification - Regulation 30(11) 20 Jan 2026 | 10:24 | Dion Global

    Ajanta Pharma Limited has informed the Exchange about Rumour Verification - Regulation 30(11)more...

  • Ajanta Pharma - Rumour verification - Regulation 30(11) 20 Jan 2026 | 10:20 | Dion Global

    Clarification on News Item Appearing in Reutersmore...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex76034.42-1.08%
NSE Index23639.15-0.95%
B500DIVL503547.840.81%
BSE 1000 10166.66-0.65%
BSE 100LCTMC8807.93-0.82%
BSE Auto 55697.6-2.92%

Commodity

Gold159809-0.21%
Silver2686010.96%
Copper1235.1202.87%
Crude Oil802125.07%
Lead197.647.02%
Mentha Oil1063.9-0.33%
Nickel1635.5113.26%

Currency

USD/INR 92.26(0.62 %)
GBP/INR 122.91(0.34 %)
EUR/INR 106.59(0.16 %)
JPY/INR 0.58(-0.13 %)
CAD/INR 67.91(0.56 %)
HKD/INR 11.80(0.67 %)